Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Current Assets (2016 - 2025)

Historic Current Assets for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $14.8 million.

  • Ekso Bionics Holdings' Current Assets fell 2976.36% to $14.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year decrease of 2976.36%. This contributed to the annual value of $18.8 million for FY2024, which is 675.48% down from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Current Assets stood at $14.8 million, which was down 2976.36% from $16.0 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Current Assets high stood at $54.6 million for Q1 2021, and its period low was $14.8 million during Q3 2025.
  • Its 5-year average for Current Assets is $30.4 million, with a median of $24.7 million in 2023.
  • Per our database at Business Quant, Ekso Bionics Holdings' Current Assets soared by 28831.6% in 2021 and then plummeted by 3915.76% in 2023.
  • Over the past 5 years, Ekso Bionics Holdings' Current Assets (Quarter) stood at $47.8 million in 2021, then crashed by 35.06% to $31.0 million in 2022, then crashed by 34.89% to $20.2 million in 2023, then decreased by 6.75% to $18.8 million in 2024, then fell by 21.48% to $14.8 million in 2025.
  • Its last three reported values are $14.8 million in Q3 2025, $16.0 million for Q2 2025, and $20.1 million during Q1 2025.